OUR ambition Bring about a paradigm shift in the field of infectious diseases AIS Biotech (where AIS stands for Anti Infective Sugar) is a French biotech company founded in March 2023 to develop a new class of sugar-based anti-infective biotherapies, designed to mimic the natural receptors of pathogens. our technology SUGAR-BASED BIOTHERAPIES AS A NEW
Location: Metropolitan France